TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.49
-0.05 (-3.25%)
At close: Jun 26, 2025, 3:59 PM
1.51
1.34%
After-hours: Jun 26, 2025, 07:15 PM EDT
TScan Therapeutics Revenue
TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending March 31, 2025, TScan Therapeutics generated $2.17M in revenue.
Revenue (ttm)
$2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
$14.08K
Employees
200
Market Cap
84.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|